The selective inhibition of the D 1 dopamine receptor results in an increase of metabolized dopamine in the rat striatum

Neurochemical Research

Volumn 37, Issue 8, 2012, Pages 1783-1789

  Bueno Nava, A ^a,b   Gonzalez Pina, R ^b   Alfaro Rodriguez, A ^b   Avila Luna, A ^b   Arch Tirado, E ^b   Alonso Spilsbury, M ^c  

^a UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^b INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^c DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Dopamine; Dopaminergic system; Monoamine oxidase; Rat; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE 1 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOLECULAR DYNAMICS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; 3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; PARGYLINE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1;

RATTUS; RATTUS NORVEGICUS;

EID: 84864343447     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0790-5     Document Type: Article

References (29)

1. Groenewegen HJ (2003) The basal ganglia and motor control. Neural Plast 10:107-120
2. Kreitzer AC, Malenka RC (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60:543-554
3. Bolam JP, Hanley JJ, Booth PAC, Bevan MD (2000) Synaptic organisation of the basal ganglia. J Anat 196:527-542
4. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-370
5. Palermo-Neto J (1997) Dopaminergic systems. Dopamine receptors. Psychiatr Clin N Am 20:705-721
6. Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30:228-235
7. Brazhnik E, Shah F, Tepper JM (2008) GABAergic afferents activate bothGABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo. J Neurosci 28:10386-10398
8. Imperato A, Di Chiara G (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156:385-393
9. Rahman S, McBride JW (2001) D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). J Neurochem 77:1248-1255
10. Saklayen SS, Mabrouk OS, Pehek EA (2004) Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors. J Pharmacol Exp Ther 311:342-348
11. Bueno-Nava A, González-Piña R, Ávila-Luna A, Alfaro-Rodríguez A (2011) Paradigm of negative feedback via long-loop in the striatal dopamine release modulation in the rat. Rev Neurol 52:371-377
12. Tomiyama K, Koshikawa N, Funada K, Oka K, Kobayashi M (1995) In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J Neurochem 65: 2790-2795
13. Saigusa T, Aono Y, Sekino R, Uchida T, Takada K, Oi Y, Koshikawa N (2009) Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of SKF38393. Eur J Pharmacol 624:10-15
14. Sekino R, Saigusa T, Aono Y, Uchida T, Takada K, Oi Y, Koshikawa N (2010) Dopamine D1-like receptors play only a minor role in the increase of striatal dopamine induced by striatally applied SKF38393. Eur J Pharmacol 648:80-86
15. Zackheim JA, Abercrombie ED (2001) Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Brain Res Bull 54:603-607
16. Abraini JH, Fechtali T, Rostain JC (1994) Lasting effects of dopamine receptor agonists upon striatal dopamine release in free-moving rats: an in vivo voltammetric study. Brain Res 642:199-205
17. Imperato A, Mulas A, Di Chiara G (1987) The D-1 antagonist SCH23390 stumulates while the D-1 agonist SKF38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur J Pharmacol 142:177-181
18. LGJr Harsing (2008) Dopamine and the dopaminergic systems of the brain. In: Lajtha A (ed) The handbook of neurochemistry and molecular neurobiology: neural membranes and transport, 3rd edn. Springer, Berlin, pp 149-170
19. Besson MJ, Cheramy A, Fetz P, Glowinski J (1969) Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci USA 62:741-748
20. Besson MJ, Cheramy A, Gauchy C, Glowinski J (1973) In vivo continuous estimation of 3H-DA synthesis an release in the cat caudate nucleus:effects of a-MPT and transaction of the nigro neostriatal pathway. Naunyn Schmiedebergs Arch Pharmacol 278:101-105
21. Glowinski J (1975) Properties and functions of intraneuronal monoamine compartments in central aminergic neurons. In: Iversen LL, Iversen SD, Snyder SH (eds) The handbook of psychopharmacology 3. Plenum Press, New York, pp 139-167
22. Cooper JR, Bloom FE, Roth RH (1996) The biochemical basis of neuropharmacology, 7th edn. Oxford University Press, New York/Oxford, pp 293-351
23. Olfert ED, Cross BM, Mc William AA (1993) Guide for the care and use of experimental animals. Can Counc Anim Care 1:211
24. Festing MF (1994) Reduction of animal use: experimental design and quality of experiments. Lab Anim 28:212-221
25. Bueno-Nava A, Gonzalez-Pina R, Alfaro-Rodriguez A (2010) Iron-dextran injection into the substantia nigra in rats decreases striatal dopamine content ipsilateral to the injury site and impairs motor function. Metab Brain Dis 25:235-239
26. Zetterström T, Sharp T, Collin AK, Ungerstedt U (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur J Pharmacol 148:327-334
27. Pan JT, Lookingland KJ, Moore KE (1995) Differential effects of corticotropin-releasing hormone on central dopaminergic and noradrenergic neurons. J Biomed Sci 2:50-56
28. Rasheed N, Ahmad A, Pandey CP, Chaturvedi RK, Lohani M, Palit G (2010) Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem Res 35:22-32
29. Kalivas PW, Duffy P, Latimer LG (1987) Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther 242:757-763